Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A.

Luo, Qing; Shi, Xuan; Ding, Jiarong; Ma, Zhenzhen; Chen, Xumei; Leng, Yuanxiu; Zhang, Xuhui; Liu, Yang

Luo, Qing; Shi, Xuan; Ding, Jiarong; Ma, Zhenzhen; Chen, Xumei; Leng, Yuanxiu; Zhang, Xuhui; Liu, Yang.

Afiliación

Luo Q; Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Shi X; Department of Anaesthesiology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Ding J; Department of Nephrology, Shanghai Changhai Hospital, Shanghai, China.
Ma Z; Department of Orthopedics, No. 371 Central Hospital of PLA, Xinxiang, Henan, China.
Chen X; Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Leng Y; Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Zhang X; Department of Orthopedics, No. 371 Central Hospital of PLA, Xinxiang, Henan, China.
Liu Y; Department of Orthopedics, No. 371 Central Hospital of PLA, Xinxiang, Henan, China.

Evid Based Complement Alternat Med ; 2019: 1410495, 2019.

Article en En | MEDLINE | ID: mdl-30723510

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2019 Tipo del documento: Article País de afiliación: China